Overview
Bronchogen (AEDL) is a synthetic short-chain peptide bioregulator developed specifically to target the respiratory system, bronchial walls, and lung tissue.
What problem it targets: It addresses chronic bronchial inflammation, respiratory fatigue, coughing, exercise-induced asthma, environmental lung stress, and impaired airway repair.
What It Does
• Restores bronchial epithelial cell function: Interacts directly with DNA in lung and bronchial tissues to stimulate cell division and repair damaged airway lining cells.
• Clears chronic airway inflammation: Suppresses pro-inflammatory cytokines and decreases mucus hypersecretion, helping restore clear, unconstricted airway passages.
• Enhances respiratory stamina: Improves oxygen exchange efficiency and cellular defense mechanisms against airborne toxins, smoke, and pollutants.
• Realistic expectations: Typically administered in 10- to 20-day cycles a few times per year. It does not act as an immediate acute bronchodilator (like an albuterol inhaler), but builds long-term tissue resilience.
Reconstitution
| Vial Size | BAC Water / Solvent | Concentration |
|---|---|---|
| 20 mg | + 4 mL | 5 mg/mL |
Reconstitution Calculator
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Enter a target amount you already have and select the syringe capacity.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
Protocol
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Course (10–20 days) | Daily | 1–2 mg SubQ | SubQ. (Oral bioregulator dosing runs higher, 10–20 mg/day.) |
| Between courses | – | – | 1–3 courses per year. |
10–20 day course, 1–3×/year.
any time. Note: respiratory-targeted bioregulator; evidence is largely Russian research, limited Western RCTs.
Unisex peptide bioregulator, short courses, no sex-specific dosing; minimal human data. Avoid in pregnancy.
